Spend Transparency Reporting Made Simple
We help you stay ahead of the complex and ever-changing regulatory landscape.
In the United States, the pharmaceutical, medical device, and biologics industries are required to report payments and transfers of value (“spend”) to healthcare professionals, healthcare facilities, and hospitals. Also known as “Aggregate Spend” and “Sunshine” reporting, QPharma provides industry-leading consulting and technology solutions to help life sciences companies comply with not only reporting requirements but spend limits, gift bans, and monitoring activities.
Individual states have their own requirements, and companies are finding themselves increasingly frustrated by the challenges of complying with varying guidelines on which activities must be reported, and how reports must be submitted.
The prospect of more states adopting similar legislation in response to the Physician Payments Sunshine Act will only increase these challenges.
Track, evaluate, and report expense transactions in a compliant manner with Ti Spend
It’s easy to see why pharmaceutical, medical device and biologics companies choose QPharma.
State transparency regulations also include requirements for specific mandates in a manufacturer’s Compliance Program and Code of Conduct, gift bans and spend limits. QPharma’s team of in-house compliance Subject Matter Experts helps clients ensure they remain compliant with all the additional individual requirements, even when reporting is not required. QPharma experts stay current on the latest federal, state, region, and city laws and provide clients with regulatory alerts as part of QPharma standard transparency services. With Titanium our clients have access to:
Comprehensive Compliance Management
Ti Spend ensures adherence to both federal and state transparency and reporting regulations, helping clients navigate complex compliance landscapes with ease.
Accurate Spend Tracking and Reporting
Records every transaction detail, including payer, recipient, purpose, and date, ensuring data accuracy for compliance and reporting.
Proven Implementation Methodology
Ti Spend utilizes a proven methodology for implementation, ensuring smooth integration and reliable performance.
Robust Data Management
Offers powerful data validation against Open Payments and state databases, ensuring all reportable recipients are accurately identified and documented.
Flexible Integration Capabilities
Adapts to any data system and can handle multiple data sources, providing a tailored fit for each client's specific needs.
Expert-Driven Oversight
Managed by QPharma's subject matter experts who oversee data submissions, dispute resolutions, and proactive data monitoring to maintain compliance.
Vendor Data Management
Streamlines the capture and management of vendor data feeds, enhancing the efficiency and reliability of data collection.
Proactive Compliance Monitoring
Continuously monitors for spend limits and state gift bans, providing proactive alerts to prevent compliance issues.
Open Payments Dispute Resolution Support
Offers dedicated support for resolving disputes in Open Payments reporting, reducing the burden on your team.
Comprehensive Business Reviews
Regular status meetings and business reviews keep your compliance strategy aligned with regulatory requirements and business goals.
Your Trusted Experts on Sunshine Act Reporting Compliance
Need help maintaining transparency and compliance? We can help.